These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 22014098)

  • 21. The early implementation of Trypanosoma cruzi antibody screening of donors and donations within England: preempting a problem.
    Kitchen AD; Hewitt PE; Chiodini PL
    Transfusion; 2012 Sep; 52(9):1931-9. PubMed ID: 22414025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The blood donor in sub-Saharan Africa: a review.
    Tagny CT; Owusu-Ofori S; Mbanya D; Deneys V
    Transfus Med; 2010 Feb; 20(1):1-10. PubMed ID: 19725906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surveillance of risk profiles among new and repeat blood donors with transfusion-transmissible infections from 1995 through 2003 in the Netherlands.
    Van der Bij AK; Coutinho RA; Van der Poel CL
    Transfusion; 2006 Oct; 46(10):1729-36. PubMed ID: 17002629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reasons for blood donation deferral in sub-Saharan Africa: experience in Ivory Coast.
    Kouao MD; Dembelé B; N'Goran LK; Konaté S; Bloch E; Murphy EL; Lefrère JJ
    Transfusion; 2012 Jul; 52(7 Pt 2):1602-6. PubMed ID: 22780941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Main causes of pre-donation deferral of prospective blood donors in the Singapore Blood Transfusion Service.
    Lim JC; Tien SL; Ong YW
    Ann Acad Med Singap; 1993 May; 22(3):326-31. PubMed ID: 8373113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bacterial contamination of blood components: Norwegian strategies in identifying donors with higher risk of inducing septic transfusion reactions in recipients.
    Klausen SS; Hervig T; Seghatchian J; Reikvam H
    Transfus Apher Sci; 2014 Oct; 51(2):97-102. PubMed ID: 25242310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Updated characteristics of blood services, donors and blood products in 11 French-speaking African countries.
    Tagny CT; Laperche S; Murphy EL;
    Vox Sang; 2018 Oct; 113(7):647-656. PubMed ID: 30125053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The revision of the European blood directives: A major challenge for transfusion medicine.
    Folléa G; Aranko K;
    Transfus Clin Biol; 2015 Aug; 22(3):141-7. PubMed ID: 26056039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two decades of risk factors and transfusion-transmissible infections in Dutch blood donors.
    Slot E; Janssen MP; Marijt-van der Kreek T; Zaaijer HL; van de Laar TJ
    Transfusion; 2016 Jan; 56(1):203-14. PubMed ID: 26355711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequency and reasons of donor deferral prior to blood donation process: a single centre experience.
    Khurram S; Borhany M; Anwar N; Naseer I; Boota S; Mirza I; Nadeem M; Shamsi T
    Transfus Med; 2017 Feb; 27(1):10-15. PubMed ID: 27730692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors that motivate and hinder blood donation in Greece.
    Marantidou O; Loukopoulou L; Zervou E; Martinis G; Egglezou A; Fountouli P; Dimoxenous P; Parara M; Gavalaki M; Maniatis A
    Transfus Med; 2007 Dec; 17(6):443-50. PubMed ID: 18067648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is there a risk of transfusion-transmissible infections after percutaneous needle treatments in blood donors? A systematic review and meta-analysis.
    Van Remoortel H; Moorkens D; Avau B; Compernolle V; Vandekerckhove P; De Buck E
    Vox Sang; 2019 May; 114(4):297-309. PubMed ID: 30972765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The History and Challenges of Blood Donor Screening in China.
    Li L; Li KY; Yan K; Ou G; Li W; Wang J; Song N; Tian L; Ji X; Chen Y; Liang X; Liu Z; Wu Y
    Transfus Med Rev; 2017 Apr; 31(2):89-93. PubMed ID: 28012709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A retrospective study of the practice of "look-back" procedures, on the incidence of HIV-1/2-positive blood donors and the risk of transfusion-associated HIV infection in public-community blood banks in Germany].
    Zeiler T; Kretschmer V; Sibrowski W
    Infusionsther Transfusionsmed; 1994 Dec; 21(6):362-7. PubMed ID: 7873914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experience with routine total nonfasting blood cholesterol screening of volunteer blood and component donors.
    Eason S; Goudar S; Centilli J; Sayers M
    Transfusion; 2011 Apr; 51(4):731-6. PubMed ID: 20977488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Do deferred donors continue their donations? A large-scale register study on whole blood donor return in the Netherlands.
    Spekman MLC; van Tilburg TG; Merz EM
    Transfusion; 2019 Dec; 59(12):3657-3665. PubMed ID: 31621923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prevalence of sickle cell trait in blood donors at the regional blood transfusion center in the Haute Matsiatra Region, Madagascar].
    Fenomanana J; Rakotoniaina I; Manantsoa SN; Randriamahenina H; Randriamanantany ZA
    Pan Afr Med J; 2020; 36():329. PubMed ID: 33193983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Access to blood donation of men who have sex with men and impact on the risk of HIV transmission by transfusion: international overview].
    Pillonel J; Semaille C
    Transfus Clin Biol; 2011 Apr; 18(2):151-7. PubMed ID: 21398161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Whole blood donor behavior and availability after deferral: Consequences of a new ferritin monitoring policy.
    Spekman MLC; Ramondt S; Sweegers MG
    Transfusion; 2021 Apr; 61(4):1112-1121. PubMed ID: 33368385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Donors' perspectives on self-deferral of men having sex with men from blood donation.
    Lee CK; Lee KC; Lin CK; Lee SS
    Transfusion; 2013 Oct; 53(10 Pt 2):2441-8. PubMed ID: 23927759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.